Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Materially Debt Free PR

<< Previous

Bullboard Posts

Next >>

Comment by okgonowon Sep 17, 2024 9:51am

63 Views

Post# 36226975

RE:Materially Debt Free PR

CADInvestor12 wrote: In the PR they state having more than $13M in cash on balance sheet ... based on Q2 results, approx $3M in cash burn QoQ .. Q3 revenue flat or declining? While nice being debt free, this is not the PR we needed and I don't think it's material to the business.

cash burn since Q4 2023 3.6mill with 2.1 mill debt repayment (Q1

started with 18mill in bank looks like they are cah flow positive to me

18mill-5.7 mill is 12.3 mill

and they say they have more than 13 mill in the bank now

is my math wrong???

<< Previous

Bullboard Posts

Next >>

How to navigate the ups and downs of investing in AI